• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Enrofloxacin

Enrofloxacin

Product ID E5369
Cas No. 93106-60-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $90.00 In stock
10 g $143.00 In stock
50 g $676.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Enrofloxacin is a fluoroquinolone antibiotic that is clinically used in veterinary medicine. Enrofloxacin inhibits bacterial DNA gyrase, displaying antibacterial efficacy against broad spectrum aerobic bacteria.

Product Info

Cas No.

93106-60-6

Purity

≥98%

Formula

C19H22FN3O3

Formula Wt.

359.39

IUPAC Name

1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3- carboxylic acid

Synonym

1,4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid, Baytril

Melting Point

219-223°C

Solubility

Slightly soluble in water, ethanol. Soluble in DMF (10 mg/mL).

Appearance

Light yellow to light orange crystal

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

E5369 MSDS PDF

Info Sheet

E5369 Info Sheet PDF

References

Cengiz M, Sahinturk P, Sonal S, et al. In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals. Vet Rec. 2013 May 4;172(18):474. PMID: 23605176.

Rzedzicki J, Boś M, Kolasa A. Influence of antibiotics on growth dynamics and movement ability of Salmonella rods. Pol J Vet Sci. 2004;7(4):267-74. PMID: 15633786.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P5747

    Polymyxin B sulfate

    Cationic lipid polypeptide, mixture of polymyxi...

    ≥6500 iu/mg
  • N4974

    NMS-E628

    ALK and Ros1 inhibitor, Trk antagonist.

    ≥98%
  • C5618

    Coelenterazine, natural

    Light-emitting luciferin analog found in aquati...

    ≥98%
  • T564091

    β-Tocopherol

    Vitamin E component

    ≥98%
  • H1648

    Hemorphin-7

    Endogenous opioid peptide derived from the β-c...

    ≥95%
  • G720004

    GS-4997

    ASK1 inhibitor.

    ≥99%
  • H189921

    1,2,3,4,5,6-Hexabromocyclohexane

    JAK2 inhibitor

    ≥98%
  • M4452

    MLN2480

    Raf inhibitor.

    ≥98%
  • A5287

    Angiotensinogen (1-14), human

    Peptide fragment, renin substrate, precursor to...

    ≥95%
  • C9881

    Cytochalasin D

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • C1649

    β-Cembrenediol

    Diterpene found in Anisomeles.

    ≥99%
  • P4132

    PKI-402

    p110α PI3K and mTOR inhibitor.

    ≥98%
  • D1722

    Defactinib

    FAK inhibitor.

    ≥98%
  • S771337

    STING Agonist-1

    Indirect activator of STING signaling

    ≥98%
  • T5968

    Torsemide

    Loop diuretic; NKCC symporter and HSP90 inhibit...

    ≥99%
  • A2532

    AGI-6780

    Isocitrate dehydrogenase inhibitor.

    ≥98%
  • D8014

    DU-14

    Steroid sulfatase inhibitor.

    ≥98%
  • V344761

    Vitamin K2

    2-methyl-1,4-naphthoquinone derivative

    ≥98%
  • E8419

    Everolimus

    mTORC1 inhibitor.

    ≥98%
  • V0145

    Valinomycin

    Peptide, neutral ionophore.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only